Aequus Pharmaceuticals Inc. (TSXV:AQS)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Apr 25, 2025, 9:30 AM EST

Aequus Pharmaceuticals Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
11351513
Market Cap Growth
-66.67%-60.00%-28.57%-69.56%13.57%33.57%
Enterprise Value
78771514
Last Close Price
0.010.010.030.040.120.12

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
0.722.2713.013.365.625.18
PB Ratio
-0.10-0.20-0.77-3.368.5323.40
P/TBV Ratio
----8.5323.40

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
7.8713.4228.614.835.355.21

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-0.87-1.02-1.18-2.021.224.05
Net Debt / Equity Ratio
-0.87-1.02-1.14-1.84-0.141.05
Net Debt / EBITDA Ratio
--3.09-1.74-0.980.16-0.88
Net Debt / FCF Ratio
-51.92-3.96-2.13-1.300.22-0.74
Asset Turnover
1.740.620.180.460.731.08
Inventory Turnover
7.593.121.020.890.33-
Quick Ratio
0.030.020.040.241.386.50
Current Ratio
0.030.040.090.381.467.20
Return on Equity (ROE)
----1569.60%-153.16%-
Return on Assets (ROA)
-68.07%-140.95%-126.92%-53.45%-26.85%-20.28%
Return on Capital Employed (ROCE)
8.30%35.50%76.00%376.30%-85.00%-28.40%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-98.97%-164.19%-89.41%-69.15%-11.86%-7.78%
FCF Yield
-17.47%-124.85%-69.18%-42.06%-7.71%-6.08%
Buyback Yield / Dilution
----2.94%-38.28%-15.86%